Clinical impact of relative dose intensity of cabozantinib during the first 8 weeks and of subsequent dose reductions in patients with unresectable hepatocellular carcinoma
Titel:
Clinical impact of relative dose intensity of cabozantinib during the first 8 weeks and of subsequent dose reductions in patients with unresectable hepatocellular carcinoma
Auteur:
Tovoli, F. Dadduzio, V. De Lorenzo, S. Rimassa, L. Masi, G. Iavarone, M. Marra, F. Garajova, I. Brizzi, M.P. Daniele, B. Trevisani, F. Messina, C. Clemente, F. Di Pini, S. Cabibbo, G. Granito, A. Rizzato, M.D. Zagonel, V. Brandi, G. Pressiani, T. Federico, P. Vivaldi, C. Bergna, I. Campani, C. Piscaglia, F.